|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/574 | (2006.01) |
| (11) | Patento numeris | 2764364 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12775896.9 |
| Europos patento paraiškos padavimo data | 2012-10-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-08-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-08-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/058871 |
| Data | 2012-10-05 |
| (87) | Numeris | WO 2013/052745 |
| Data | 2013-04-11 |
| (30) | Numeris | Data | Šalis |
| 201161544206 P | 2011-10-06 | US | |
| 201261636183 P | 2012-04-20 | US |
| (72) |
VINCENT, Sylvie , US
MEETZE, Kristan , US
FENG, Bin , US
TYLER, Steven , US
BOTTEGA, Steve , US
NICOLETTI, Richard , US
MCINTOSH, Donna , US
GYURIS, Jeno , US
|
| (73) |
Aveo Pharmaceuticals, Inc. ,
30 Winter Street, Boston MA 02108,
US
|
| (54) | PREDICTING TUMOR RESPONSE TO ANTI-ERBB3 ANTIBODIES |
| PREDICTING TUMOR RESPONSE TO ANTI-ERBB3 ANTIBODIES |